Showing 6,049 results

Filters Content type: News, Editors' picks, About HIV Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Epidemiology

No improvements in CD4 count at diagnosis in African patients in last decade

News
4 February 2015
Bone & joint problems

Screening for bone fracture risk should be routine for over-40s with HIV, new guidelines recommend

News
2 February 2015
New & experimental HIV treatments

Treatment of the First HIV Positive Patient in ABIVAX's Phase IIa Clinical Trial With ABX464

Editor's pick
ABIVAX press release
2 February 2015
New & experimental HIV treatments

PREZCOBIX™ (darunavir/cobicistat) approved in the U.S. for the treatment of adults living with HIV-1

Editor's pick
Janssen press release
30 January 2015
New & experimental HIV treatments

U.S. Food and Drug Administration approves Bristol-Myers Squibb’s Evotaz™ (atazanavir and cobicistat) for the treatment of HIV-1 infection in adults

Editor's pick
Bristol-Myers Squibb press release
30 January 2015
Bad science & bogus treatments

African American people’s AIDS conspiracy beliefs best understood in terms of social anxiety and distrust, not ignorance

News
29 January 2015
Access to healthcare

Russia may face shortage of anti-AIDS drugs in 2015

Editor's pick
EATG
29 January 2015
Bad science & bogus treatments

Déjà Vu – Claims of HIV Cures and Re-Treading Old Ground

Editor's pick
Nigeria Health Watch
28 January 2015
Viral load

An HIV Doctor Tells You If Undetectable Really Is the New Negative

Editor's pick
The Body
28 January 2015
Neurological & cognitive problems

Antiretroviral Neurotoxicity May Cause Cognitive Problems

Editor's pick
The Body Pro
28 January 2015
Cardiovascular disease

Smoking is the main cause of increased risk of heart attack in people with HIV

News
28 January 2015
Adherence

Adherence packaging battles HIV/AIDS in Africa, India

Editor's pick
Packaging World
26 January 2015
Bad science & bogus treatments

Why scientific AIDS explanations struggle in townships

Editor's pick
Africa Check
26 January 2015
HIV prevention policy

Bill Gates Predicts Two Miracles for AIDS Relief by 2030

Editor's pick
Bloomberg
26 January 2015
Pharmaceutical industry

Merck (MRK) Receives Positive CHMP Opinion for Dutrebis as HIV 1 Treatment

Editor's pick
Street Insider
26 January 2015
Cancer

Low CD4 count, suboptimal HIV treatment linked to higher anal cancer risk

Editor's pick
HIVandHepatitis.com
23 January 2015
Treatment outcomes & life expectancy

Starting HIV treatment early and then interrupting is no better than delaying it

News
22 January 2015
Resistance

Exploring possible treatment options after virological failure with raltegravir

Editor's pick
CATIE
21 January 2015
New & experimental HIV treatments

New anti HIV drug dolutegravir is effective at low doses

Editor's pick
MMD Newswire
21 January 2015
Pregnancy and vertical transmission

HIV—Pregnancy-related issues

Editor's pick
CATIE
20 January 2015
Side effects

Zimbabwe finally switches away from stavudine

Editor's pick
AllAfrica
19 January 2015
Cardiovascular disease

Dramatic decline in risk for heart attacks among HIV-positive Kaiser Permanente members

Editor's pick
Eurekalert
19 January 2015
PrEP

Drug Resistance, While Rare, Can Occur After Contracting HIV on PrEP

Editor's pick
AIDSMeds
16 January 2015
Access to healthcare

Hepatitis C drug delayed by NHS due to high cost

Editor's pick
The Guardian
16 January 2015